Table 2.
Biochemical and hormonal parameters in both treatment arms following intervention with calcifediol
| Parameter | 50 µg-group (n=35) | 25 µg-group (n=29) | P |
|---|---|---|---|
| 4 weeks | |||
| Ca (mg/dL) | 9.1±0.3 | 9. 4±0.5 | 0.71 |
| PO4 (mg/dL) | 3.3±0.6 | 3.6±0.6 | 0.23 |
| Albumin (g/dL) | 4.4±0.4 | 4.4±0.6 | 0.63 |
| ALP (IU/L) | 84.0±27.9 | 99.7±34.8 | 0.06 |
| 25(OH)D (ng/mL) | 84.0±27.7 | 58.0±23.6 | 0.0002 |
| PTH (pg/mL) | 54.4±16.4 | 50.5±17.6 | 0.37 |
| 1,25 (OH)2D (pg/mL) | 171.5±74.8 | 165.3±56.7 | 0.67 |
| 8 weeks | |||
| Ca (mg/dL) | 9.1±0.3 | 9.2±0.4 | 0.98 |
| PO4 (mg/dL) | 3.6±0.5 | 3.7±0.7 | 0.58 |
| Albumin (g/dL) | 4.4±0.5 | 4.3±0.4 | 0.67 |
| ALP (IU/L) | 88.8±27.5 | 90.0±24.5 | 0.91 |
| 25(OH)D (ng/mL) | 94.3±21.8 | 76.0±16.4 | 0.001 |
| PTH (pg/mL) | 51.6±16.0 | 43.9±16.0 | 0.06 |
| 1,25 (OH)2D (pg/mL) | 234.5±102.8 | 203.3±85.3 | 0.18 |
ALP: Alkaline phosphatase, PTH: Parathyroid hormone, PO4: Phosphate, 25(OH)D: 25-hydroxyvitamin D, 1,25(OH)2D: 1,25-dihydroxyvitamin D